In contrast, activation of GPD2, which alters its substrate affinity, preferentially converts G3P to DHAP and transforms it into glycolytic catalysis, thus promoting the proliferation of glioma cells [35]. This evidence concerns the gene GPD2 and central nervous system cancer.